Delivery Order SPE2DR25D2006-SPE2DR26F56PE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,195.54 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price delivery order was not designated as a set-aside contract and represents a competitive award under the company's existing indefinite delivery contract vehicle. Performance will take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.62 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials. This contract employs firm fixed price terms with an ultimate completion date of November 25, 2025, and was awarded competitively without a set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $11,180.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 26, 2025. This non-set-aside contract was awarded competitively on September 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a $16,108.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for M-M-R II vaccine vials. The contract, which is a non-set-aside competitive award, carries an ultimate completion date of November 13, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $12,034.65 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a routine pharmaceutical supply fulfillment under the company's existing relationship with DLA. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,925.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 11, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's standard federal procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,797.70 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order, processed without a set-aside designation, represents a competitive procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,175.66 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a single transaction under AmerisourceBergen's broader federal contract portfolio supporting military and veteran healthcare procurement needs....
- The Defense Logistics Agency awarded a $17,531.26 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of October 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical supplier for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for M-M-R II vaccine vials valued at $15,511.96 with a firm fixed price contract type. The order is scheduled for completion by December 11, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56PEDelivery Order
The Defense Logistics Agency awarded a $25,723 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials under a firm fixed-price contract without set-aside designation. The delivery order was executed on December 8, 2025, with an ultimate completion date of December 9, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award represents a small-value transaction within AmerisourceBergen's broader federal medical supply portfolio, which emphasizes the company's role as a critical pharmaceutical distributor supporting military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply vaccines, medications, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's competitively awarded contracts demonstrate its capability to meet federal procurement requirements across a wide spectrum of medical products, from routine pharmaceutical commodities to specialized healthcare supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.7k | 12/7/25 |